"There was no intent to harm the medical marijuana industry in any way, certainly not the patients. In fact, we understand and appreciate the medicinal value medical marijuana has in relieving chronic pain and other medical ailments. This was also a message we conveyed when we announced our decision," said Welch in a statement.